These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 28548958)
41. Association between -174G>C polymorphism in the IL-6 promoter region and the risk of obesity: A meta-analysis. Hu M; Yu Z; Luo D; Zhang H; Li J; Liang F; Chen R Medicine (Baltimore); 2018 Aug; 97(33):e11773. PubMed ID: 30113463 [TBL] [Abstract][Full Text] [Related]
42. The increased plasma C-reactive protein and interleukin-6 levels in patients undergoing coronary artery bypass grafting surgery are associated with the interleukin-6-174G > C gene polymorphism. Wypasek E; Undas A; Sniezek-Maciejewska M; Kapelak B; Plicner D; Stepien E; Sadowski J Ann Clin Biochem; 2010 Jul; 47(Pt 4):343-9. PubMed ID: 20592333 [TBL] [Abstract][Full Text] [Related]
43. Functional polymorphisms in the IL6 gene promoter and the risk of urinary bladder cancer in India. Gautam KA; Muktanand T; Sankhwar SN; Goel A; Sankhwar PL; Rajender S Cytokine; 2016 Jan; 77():152-6. PubMed ID: 26605964 [TBL] [Abstract][Full Text] [Related]
44. Meta-analysis: Interleukin 6 gene -174G/C polymorphism associated with type 2 diabetes mellitus and interleukin 6 changes. Cheng H; Zhu W; Zhu M; Sun Y; Sun X; Jia D; Yang C; Yu H; Zhang C J Cell Mol Med; 2021 Jun; 25(12):5628-5639. PubMed ID: 33960655 [TBL] [Abstract][Full Text] [Related]
45. Interleukin-6 promoter polymorphism and plasma levels in patients with schizophrenia. Zakharyan R; Petrek M; Arakelyan A; Mrazek F; Atshemyan S; Boyajyan A Tissue Antigens; 2012 Aug; 80(2):136-42. PubMed ID: 22571276 [TBL] [Abstract][Full Text] [Related]
46. Association between the -607 C > A polymorphism in interleukin-18 gene promoter with gastrointestinal cancer risk: a meta-analysis. Yao J; Li ZH; Li YX; Zhang R; Zhang DG; Xu ZL; Wang LS; Wang JY Genet Mol Res; 2015 Dec; 14(4):16880-7. PubMed ID: 26681034 [TBL] [Abstract][Full Text] [Related]
47. Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer. DeMichele A; Martin AM; Mick R; Gor P; Wray L; Klein-Cabral M; Athanasiadis G; Colligan T; Stadtmauer E; Weber B Cancer Res; 2003 Nov; 63(22):8051-6. PubMed ID: 14633738 [TBL] [Abstract][Full Text] [Related]
48. Polymorphisms in promoter regions of IL-6 and IL-10 genes in breast cancer: a case-control study. AlSuhaibani ES; Kizilbash NA; Malik S; Dasti JI; Al Beladi F; El-Morshedi N Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27050979 [TBL] [Abstract][Full Text] [Related]
49. Association of IL-6 -174G>C and -572G>C Polymorphisms with Susceptibility to Cervical Cancer and Ovarian Cancer. Hashemzehi A; Karimi-Zarchi M; Parsaeian SF; Asadian F; Golestanpour H; Setayesh S; Shaker SA; Zare-Shehneh M; Neamatzadeh H Asian Pac J Cancer Prev; 2021 Sep; 22(9):2867-2871. PubMed ID: 34582655 [TBL] [Abstract][Full Text] [Related]
50. C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance. Cardellini M; Perego L; D'Adamo M; Marini MA; Procopio C; Hribal ML; Andreozzi F; Frontoni S; Giacomelli M; Paganelli M; Pontiroli AE; Lauro R; Folli F; Sesti G Diabetes Care; 2005 Aug; 28(8):2007-12. PubMed ID: 16043746 [TBL] [Abstract][Full Text] [Related]
51. Association between IL-6-174G/C polymorphism and risk of multiple sclerosis: a meta-analysis. Hu S; Chen Y; Sun XD; Li FJ; Shu QF; Liu XL; Jiang SF Genet Test Mol Biomarkers; 2014 Feb; 18(2):127-30. PubMed ID: 24328460 [TBL] [Abstract][Full Text] [Related]
52. Interleukin-6 promoter variants, prostate cancer risk, and survival. Tindall EA; Severi G; Hoang HN; Southey MC; English DR; Hopper JL; Giles GG; Hayes VM; Prostate; 2012 Dec; 72(16):1701-7. PubMed ID: 22782910 [TBL] [Abstract][Full Text] [Related]
53. The interleukin-6 -174G/C polymorphism and prostate cancer risk: a systematic review and meta-analysis. Zhang H; Xu Y; Li L; Liu R; Ma B Urol Int; 2012; 88(4):447-53. PubMed ID: 22516897 [TBL] [Abstract][Full Text] [Related]
54. Interleukin-6 gene -174 G/C promoter polymorphism predicts severity and outcome in acute ischemic stroke patients from north India. Chakraborty B; Chowdhury D; Vishnoi G; Goswami B; Kishore J; Agarwal S J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):683-9. PubMed ID: 22410655 [TBL] [Abstract][Full Text] [Related]
55. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis. Wang J; Ding Q; Shi Y; Cao Q; Qin C; Zhu J; Chen J; Yin C Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059 [TBL] [Abstract][Full Text] [Related]
56. Association of IL-6 C-174G (rs 1800795) single nucleotide polymorphism with type 2 diabetes mellitus in Pakistani population. Nadeem A; Mumtaz S; Naveed AK; Mansoor Q; Aslam M; Siddiqui A; Ismail M J Pak Med Assoc; 2017 Mar; 67(3):428-433. PubMed ID: 28303994 [TBL] [Abstract][Full Text] [Related]
57. Association between interleukin-6 -174G/C polymorphism and the risk of Alzheimer's disease: a meta-analysis. Hua Y; Guo X; Huang Q; Kong Y; Lu X Int J Neurosci; 2013 Sep; 123(9):626-35. PubMed ID: 23510010 [TBL] [Abstract][Full Text] [Related]
58. IL-1β+3953C/T, -511T/C and IL-6 -174C/G polymorphisms in association with tuberculosis susceptibility: A meta-analysis. Mao X; Ke Z; Liu S; Tang B; Wang J; Huang H; Chen S Gene; 2015 Nov; 573(1):75-83. PubMed ID: 26169021 [TBL] [Abstract][Full Text] [Related]